AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05597306 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Venetoclax
Description: Venetoclax will be administered orally once daily via tablet.
Study NCT05215600 — intervention group
Intervention type: DEVICE
Intervention: Anaverse Shoulder System
Description: Reverse Shoulder Arthroplasty
Study NCT06446024 — intervention group
Intervention type: DEVICE
Intervention: Mechanical aspiration thrombectomy
Description: Mechanical thrombectomy is an endovascular technique for removing blood clots from vessels. Penumbra's Indigo system actively extracts thrombus using a continuous vacuum pump, enabling aspiration of thrombus of various sizes and lengths.
Study NCT05742776 — intervention group
Intervention type: OTHER
Intervention: Assessment of Sleep Quality
Description: Assessment of Sleep Quality
Study NCT05257642 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: REThink Game
Description: REThink is a online therapeutic game developed by David and collaborators (2018), proved to be an efficient intervention to reduce emotional symptoms of children and adolescents.
Study NCT06066580 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sevasemten
Description: Sevasemten is administered orally once per day
Study NCT04100564 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Supraglottic airway device
Description: Initial advanced airway management with a supraglottic device
Study NCT04100564 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard airway management
Description: Initial advanced airway management with standard care method
Study NCT05073679 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Naltrexone Hydrochloride
Description: 25mg x 3 days then 50mg a day thereafter
Study NCT05073679 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Control
Description: Methylcellulose and gelatin capsule only
Study NCT04983303 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: TICK-B group
Description: These interventions will distract the child during venipuncture
Study NCT05052307 — intervention group
Intervention type: DRUG
Intervention: Pfizer/BioNTech BNT162b2 mRNA COVID-19 vaccine
Description: Pfizer/BioNTech BNT162b2 mRNA COVID-19 vaccine
Study NCT05052307 — intervention group
Intervention type: DRUG
Intervention: CoronaVac COVID-19 vaccine
Description: CoronaVac COVID-19 vaccine
Study NCT05052307 — intervention group
Intervention type: DRUG
Intervention: ChAdOx1 nCoV-19 Covid-19 Vaccine
Description: ChAdOx1 nCoV-19 Covid-19 Vaccine
Study NCT06671288 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Balloon-blowing exercises with abdominal & lumbar core muscle activation position.
Description: Patients in this group will recieve Balloon-blowing exercises with abdominal and lumbar core muscles activation position Total 4 weeks protocol will be followed in which 3 sessions per week will be supervised by physical therapist.~FREQUENCY: 3 times a week, INTENSITY : Moderate, TIME: 4 sets of balloon-blowing with 1 min rest (30 mins) TYPE: Balloon-blowing with abdominal \& lumbar core muscle activation position, DURATION : 4 weeks
Study NCT06671288 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Diaphragmatic breathing exercise
Description: Participants in this group will only be receiving diaphragmatic breathing exercise for 4 weeks. FREQUENCY: 3 times a week , INTENSITY: Moderate, TIME: 4 sets of diaphragmatic breathing with 1 min rest, TYPE: Diaphragmatic breathing, DURATION: 4 weeks
Study NCT06672328 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Training with Action Observation Therapy
Description: AOT based mobility and balance exercises along with conventional therapy consisting of simple lower limb stretchings and strengthening.~The fun based activities inlcude reaching for objects, tower building and taking turns in various stances.
Study NCT06672328 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Training without Action Observation Therapy
Description: Cerebral Palsy patients will receive balance and mobility training without action observation in various stances of sitting, standing and turning.~Activities are fun based and include reaching for objects, tower building and taking turns in different positions.
Study NCT06672562 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Narrative Enhancement and Cognitive Therapy
Description: NECT-Y consists of 14 90-minute sessions over the course of 14 weeks. The intervention combines psychoeducation, cognitive therapy, narrative therapy, goal-setting and peer support. Each group meeting includes educational materials, reflections, and active exercises that participants are guided through to personalize the content to their experiences. Participants will be provided with a workbook which allows them to follow the activities easier.
Study NCT06672562 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Usual care
Description: Standard usual care. No study-specific care, but participants will be provided with information on community resources and support, and will also be encouraged to speak to their clinician if they are interested in learning about other services.
Study NCT06671444 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: YZJ-1139
Description: Single oral dose, 20 mg tablet
Study NCT06673030 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Using Kaleidoscope glasses during pulpotomy procedures
Description: Kaleidoscope is an instrument that shows an infinite number of fascinating geometric shapes in the form of a flower, repeating and reflecting images of coloured goggle fragments in the front section in a prism mirroring the inner surface.
Study NCT06673030 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: The Play-Doh Doctor Drill 'n Fill toy set
Description: Consists of a plastic human head with slots into which Play-doh molded teeth can be inserted. A battery operated toy drill is used to drill into and clean the black, cavitated tooth model and filled with white Play-Doh compound to simulate cavity preparation and restoration using tooth colored cement.
Study NCT06673030 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Group 1 (Tell-Show-Do)
Description: In which Tell-Show-Do technique was done in three stages:~* Tell: The dental procedures were explained to the children using language and expressions appropriate for their age.~* Show: This began with showing the child the instruments and the topical anesthetic gel, high-speed handpiece and explaining the purpose of using the handpiece. and how the water removed using the suction device.~* Do: Performing the dental procedure immediately.
Study NCT06672835 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: eBASIS
Description: eBASIS is an online, optimized, and evidence-based practice agnostic implementation strategy that addresses the behavioral component often missing from standard evidence-based practice training and consultation. It relates to motivation before and volition after the evidence-based practice training and targets behavioral intentions by improving attitudes, subjective norms, and self-efficacy. The implementation strategy is designed to be designed to be delivered within the Preparation/Adoption phase immediately prior to the Action implementation in the EPIS model.
Study NCT06672835 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: eAttention Control
Description: eAC is an online control for eBASIS. Providers assigned to eAttention Control (eAC) will receive pre- and post-training experiences designed to mirror those received in eBASIS. These training experiences will be delivered on the same platform and be approximately the same length as the eBASIS but will not contain any eBASIS content or mechanisms of change. The eAC pre-training experience will define, describe, and advocate for evidence-based practice implementation in schools. Content in eAC will be didactic similar to a typical professional development training for providers.
Study NCT06673134 — intervention group
Intervention type: DRUG
Intervention: enteral nutrition
Description: exclusive enteral nutrition therapy or Partial enteral nutrition
Study NCT05495061 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: STN1012600 ophthalmic solution 0.002%
Description: 1 drop STN1012600 ophthalmic solution 0.002% once daily for 3 months
Study NCT05495061 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Latanoprost ophthalmic solution 0.005%
Description: 1 drop Latanoprost ophthalmic solution 0.005% once daily for 3 months
Study NCT06673134 — intervention group
Intervention type: DRUG
Intervention: Immunotherapy
Description: Immunosuppressants therapy, Including thalidomide, azathioprine, methotrexate, etc
Study NCT06673134 — intervention group
Intervention type: DRUG
Intervention: biological agents
Description: Inflixima , domestic infliximab (Taizhou Mabtech Pharmaceutical Co.,Ltd) and Adalimumab , etc
Study NCT06083948 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Noradrenalin
Description: Infusion of noradrenaline during anesthesia and surgery
Study NCT06083948 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Phenylephrine
Description: Infusion of phenylephrine during anesthesia and surgery
Study NCT06247397 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Added high-flow oxygen therapy
Description: Added high-flow oxygen therapy using the device Lumis HFT during nighttime and at the patient's discretion daytime, with the usual care (low-flow oxygen therapy) the rest of the time.
Study NCT06247397 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard care
Description: Standard care with low-flow oxygen therapy in accordance with clinical routine.
Study NCT05443347 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Description: Supervised aerobic exercise
Study NCT05443347 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Newsletter
Description: Biweekly newsletter
Study NCT05594992 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JR-141
Description: IV infusion, 2.0 mg/kg/week
Study NCT05297903 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: XmAb20717
Description: 10mg/kg IV
Study NCT05775094 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Romosozumab
Description: Romosozumab will be administered 210 mg SC as two 105 mg prefilled syringes once every 4 weeks x 12 months. No dose adjustments for romosozumab will be permitted. All efforts will be made to administer romosozumab within the defined study visit windows (+/- 14 days).
Study NCT06644261 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Bupivacaine injection
Description: Transvaginal: Palpation 1 cm superior and medial to ischial spine to locate pudendal nerve. 22 gauge spinal needle with trumpet will be placed at this location. Upon negative aspiration, 10 mL of 0.25% bupivacaine will be injected bilaterally.~Fluoroscopic: Anesthesia Pain medicine fluoroscopy guided injection of 5 mL 0.25% bupivacaine bilaterally in the area of the pudendal nerve based on surrounding landmarks
Study NCT05039229 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nozzles (NZ)
Description: Technical intervention targeting alteration of nozzles or nozzle function along the production line, e.g. by manipulation of nozzle dimensions, alteration of operating pressure or shielding of the nozzle's output stream. How the intervention is to be carried out in detail in the respective factory is to be developed in collaboration with the factory staff. This can include local specific characteristics, specific location of intervention or others.
Study NCT05039229 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cleaning of surfaces (CS)
Description: Behavioural or technical intervention. This can include increased use of swabbing instead of flushing with water hoses or alterations in use of water hoses for cleaning. Examples for the latter are a reduced flushing frequency, reduction of number of employees executing the work, alterations of hose dimension or nozzles on hoses. How the intervention is to be carried out in detail in the respective factory is to be developed in collaboration with the factory staff. This can include local specific characteristics, specific location of intervention or others.
Study NCT05052307 — intervention group
Intervention type: DRUG
Intervention: Ad26.COV2.S COVID-19 Vaccine
Description: Ad26.COV2.S COVID-19 Vaccine
Study NCT05136651 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: OurRelationship
Description: The OurRelationship Program is an online adaptation of Integrative Behavioral Couple Therapy (IBCT). It consists of 3 modules that couples complete over the course of 6-8 weeks. Couples also receive a 30-minute coaching appointment following completion of each module.
Study NCT06673134 — intervention group
Intervention type: DRUG
Intervention: Glucocorticoids
Description: Glucocorticoids treatments are given
Study NCT06278298 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Shockwave
Description: CDT and different dose of shockwave
Study NCT06278298 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: CDT
Description: CDT
Study NCT06673134 — intervention group
Intervention type: OTHER
Intervention: fecal microbiota transplantation
Description: Fecal bacteria transplantation treatment, transplantation routes include enema, TET route, capsule fecal bacteria route, etc
Study NCT06672016 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Transdermal system containing progestin
Description: MR-130A-01 transdermal system, patch to be used for female contraception
Study NCT06671132 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Computerized Chemosensory-Based Orbitofrontal Cortex Training for Pain
Description: CBOT device with beta-caryophyllene
Study NCT06671132 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: SHAM_COMPARATOR
Intervention: Computerized Chemosensory-Based Orbitofrontal Cortex Training (CBOT)
Description: CBOT device administering continuous olfactoy stimuli with no BCP
Study NCT06673329 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Brodalumab
Description: Brodalumab 210 mg subcutaneous injection
Study NCT06673329 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: CT scan
Description: CT scans within 4 weeks of starting brodalumab and every 3 months during the study for tumor assessment
Study NCT06045572 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: VTM examination and breast biopsy
Description: VTM examination performed by a radiologist, at the MART (Metabolic Activity in Real-Time) station, using the SaMD Mart 2.0, according to the inspection protocol to identify breast alterations and/or suspicious images to be biopsied for validation by genetic tests and histology / immunohistochemistry.
Study NCT05303675 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: exercise and training
Description: Preoperative: An introductory information form will be filled out, and a lymphedema self-care and exercise booklet will be given.~Postoperative: Patients will be applied Progressive Upper Limb Exercises and Muscle Relaxation Training (PULE-MRT), lymphedema upper extremity circumference measurement, and symptom alert model until discharge, and Muscle Relaxation Training will continue until discharge.~Post-Discharge: They will be asked to record a diary at home. PULE-MRT will continue until day 15. The 15-day exercise program will continue for up to 3 months. Follow-up will be made by telephone according to the symptom alert model at the 1st, 2nd, and 3rd months, and at the end of the 3rd month, the breast cancer-related lymphedema self-care scale will be administered.
Study NCT04976153 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: aSMDC
Description: Autologous Muscle Derived Cells for injection into the external anal sphincter
Study NCT04976153 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo control is the vehicle solution used for the study product
Study NCT05136651 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: OurRelationship
Description: The OurRelationship Program is an online adaptation of Integrative Behavioral Couple Therapy (IBCT). It consists of 3 modules that couples complete over the course of 6-8 weeks. Couples also receive a 30-minute coaching appointment following completion of each module.
Study NCT05247502 — intervention group
Intervention type: BIOLOGICAL
Intervention: Data observation
Description: At the time of participant inclusion in the study, demographic data and a baseline serum creatinine measurement will be collected. During the patient's ICU stay, the occurrence and duration of any AKI episode will be recorded. Data related to diagnostic examinations of these AKI episodes will also be collected in accordance with practices guidelines. Data related to AKI monitoring will also be collected, including serum creatinine and urea daily follow-up measurements, diuresis, and nephrotoxic use. The patient's need for extrarenal epuration or use of catecholamines will also be recorded. In the 3-month and 12-month.
Study NCT05182515 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Therapeutic plasma exchange
Description: Plasma exchange techniques reported in COVID-19 vary from study to study. No consensus exists on the use of a specific technique.~The use of a central venous catheter will be left to the discretion of investigators. If so, central venous catheter will be inserted through the internal jugular or femoral route under ultrasound control by a trained operator. After radiographic control of the position of the catheter and the absence of complications in the placement of the catheter, plasma exchanges will be carried out.~Three plasma exchanges of 1.5 plasma volume will be carried out every 48 hours on D1, D3 and D5. Plasma volume will be assessed by this equation VP = (1-Hct)x70xweight Body(measured). The substitution volume will be 5% albumin as first intervention. The use of a hemofiltration or centrifugation technique will be left to the discretion of each center.
Study NCT05987670 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: AI-stethoscope
Description: Clinicians at practices in the intervention arm will be provided with one session of in-person training in use of the AI-stethoscope within 2 weeks of randomisation, including~1. Delivery and setup~2. Smartphone app installation and login~3. Pairing of all clinician smartphones with all AI-stethoscopes in the same practice~4. Demo of patient examination The AI-stethoscope will be used within its CE/UKCA-marked intended purpose. The clinical guidelines for use have been agreed by the NHS North West London Integrated Care System and Betsi Cadwaladr University Health Board Cardiovascular Executive Groups. Patients will be examined with the AI-stethoscope in accordance with these guidelines, and/or where stethoscope examination is deemed clinically appropriate. Patients will provide verbal consent for examination with the AI-stethoscope as per any physical examination performed by healthcare professionals for direct care, in accordance with UK law and General Medical Council guidelines.
Study NCT06479005 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Oura Ring
Description: The Oura ring will remotely monitor the patients vitals at home continuously
Study NCT05437094 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: CRD-740
Description: CRD-740
Study NCT05437094 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Itraconazole
Description: Itraconazole
Study NCT06401538 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BMB-101
Description: BMB-101 liquid administered orally twice a day for 3 months
Study NCT05509712 — intervention group
Intervention type: BEHAVIORAL
Intervention: Focus Groups to Refine MobileMen App Content
Description: Participants are shown a clickable wireframe of the proposed new app features, including competition, animated badges, leaderboard, and incentives. Focus group members discuss perceptions, ease of use, and interest in the app design/features and identified additional or unnecessary features for adopting and maintaining physical activity (PA).
Study NCT06382688 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: NAD+ (nicotinamide adenine dinucleotide) IV
Description: NAD+ enables cells to generate cellular energy from the food that one eats
Study NCT06382688 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Niagen® (nicotinamide riboside) IV
Description: NR is a unique member of the vitamin B3 family. Cells can use NR to create nicotinamide adenine dinucleotide (NAD+), which is an essential molecule found in every living cell. Patients in this arm received an IV administration.
Study NCT06382688 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: OTHER
Intervention: Niagen® (nicotinamide riboside) oral
Description: NR is a unique member of the vitamin B3 family. Cells can use NR to create nicotinamide adenine dinucleotide (NAD+), which is an essential molecule found in every living cell. Patients in this arm received an oral administration.
Study NCT06382688 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: These individuals received a saline IV
Study NCT05863429 — intervention group
Intervention type: BIOLOGICAL
Intervention: Taking biological samples (blood) and keeping records with phone calls
Description: Within the scope of the study, no intervention will be made to the participants. According to the vaccination program implemented in Turkey, subjects who apply to the study centers for TURKOVAC vaccine will be invited to the study.
Study NCT05165394 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Tablets for oral administration
Study NCT05165394 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NBI-1065846
Description: Tablets for oral administration
Study NCT04781777 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: insulin
Description: sonar guided insulin combined with dexamethasone and local anesthetics